Gout: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• AMPK 1
• GLP-1 1
• NLRP3 1

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Updated 21 Sept 2026

  “Administrative”Registry text, quoted unchanged. Source

• Terminated

  Prednisolone Versus Colchicine for Acute Gout in Primary Care

  NCT05698680· University Medicine Greifswald· Updated 15 May 2026

  “The study was terminated due to an inability to reach the planned sample size, despite efforts to enhance recruitment.”Registry text, quoted unchanged. Source

• Withdrawn

  Prediction of Expected Length of Hospital Stay Using Machine Learning

  NCT04784351· Brigham and Women's Hospital· Updated 17 Mar 2026

  “Insufficient resources.”Registry text, quoted unchanged. Source

• Suspended

  Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

  NCT04844814· Assistance Publique - Hôpitaux de Paris· Updated 4 Feb 2026

  “Peremption of treatments, difficulty of patients recrutment (28 patients in 3 years) and lack of funding to pursue the study.”Registry text, quoted unchanged. Source

• Terminated

  Extension Study of ABP-671 in Participants With Gout

  NCT06276556· Atom Therapeutics Co., Ltd· Updated 16 Jul 2025

  “For business consideration, a new long-term safety study will be conducted in the next new pivotal studies.”Registry text, quoted unchanged. Source

• Withdrawn

  A Pilot Study to Explore the Role of Gut Flora in Gout

  NCT04224662· ProgenaBiome· Updated 5 Jun 2025

  “Company shifted focus”Registry text, quoted unchanged. Source

• Terminated

  Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare

  NCT03933007· Assistance Publique - Hôpitaux de Paris· Updated 3 Jun 2024

  “faillure of recrutement”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study of Dotinurad Versus Allopurinol in Participants With Gout

  NCT07089875· Crystalys Therapeutics· Source

• A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

  NCT07089888· Crystalys Therapeutics· Source

• The Remote Monitoring of Gout Study

  NCT06822933· Diakonhjemmet Hospital· Source

• A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

  NCT07388498· Amgen· Source

• A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

  NCT07535034· Crystalys Therapeutics· Source

• Mazdutide for Weight Management and Gout in Adults With Obesity

  NCT07824895· Hongwei Jiang· Source

• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

  NCT06229145· Amgen· Source

• Tight Control of Gouty Arthritis Compared to Usual Care

  NCT05507723· University of Edinburgh· Source

• Stop Treatment in gout

  2024-515714-40-00· Assistance Publique Hopitaux De Paris· Source

• Prednisolone Versus Colchicine for Acute Gout in Primary Care

  NCT05698680· University Medicine Greifswald· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.